Clonal hematopoiesis study for people 55+
Part of Blood & lymphatic clinical trials.
This study looks at a condition called clonal hematopoiesis (CH), where some blood cells have changes that may affect their health. It aims to prevent, treat, and better understand CH. You may qualify if you are 55 or older and have low blood counts that persist over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 55 years old or older.
- You must have a confirmed diagnosis of clonal hematopoiesis or possible CH, which includes having low blood counts (like low white cells, red cells, or platelets) that have been seen at least twice, 4 months apart.
- You must be willing to give written permission to take part in the study.
- Your low blood counts must not be severe (for example, your white count must be above 0.5, your hemoglobin above 80, and your platelets above 50).
- You must not have very low counts in more than one type of blood cell at the same time (as defined in the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medication can improve blood cell counts and reduce the risk of serious blood diseases in people with low blood counts and a specific genetic mutation. It aims to keep early changes from turning into leukemia or other blood cancers.
This study looks at how certain age-related changes in blood cells, called clonal hematopoiesis, affect inflammation and health. It aims to understand why some people with these changes develop heart problems or blood disorders, which could guide future prevention.
This study collects blood samples and health information from people with certain unexplained blood cell changes or those at higher risk for them, to learn how these changes relate to inflammation and heart health.
This study tests whether eating more plant-based whole foods can help people with clonal hematopoiesis (a condition where blood cells grow from a single mutated cell). Researchers want to understand if dietary changes affect this condition and collect health information over time.
This study follows adults who have certain blood-cell DNA changes (CHIP or CCUS) to learn how their condition may progress over time. It mainly looks at natural history—what happens in the blood without giving an active treatment.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
Hear when a new Clonal Hematopoiesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.